Sildenafil in Pulmonary Arterial Hypertension and Systemic Hypertension Management
Mechanism of Action and Approved Indications
- The European Society of Cardiology recommends sildenafil for pulmonary arterial hypertension (PAH) management, as it increases cGMP within vascular smooth muscle cells, resulting in vasodilation primarily in the pulmonary vasculature 1
Effects on Systemic Blood Pressure and Potential Risks
- Sildenafil can cause additive blood pressure-lowering effects when combined with antihypertensive medications, potentially leading to symptomatic hypotension, as noted by the European Heart Journal 1
- The American Heart Association acknowledges that common side effects of sildenafil include headache, flushing, epistaxis, and visual disturbances, with headache reported in 34-57% of patients 2
Appropriate Use in Pulmonary Hypertension
- Sildenafil is effective for pulmonary arterial hypertension (PAH), improving exercise capacity, functional class, and hemodynamic parameters, according to Circulation Research and Chest 3, 4
Clinical Considerations
- The European Heart Journal suggests that if a patient has both systemic hypertension and PAH, standard antihypertensive medications should be used for systemic hypertension management, while sildenafil may be appropriate for PAH 1
- Care is needed when PAH-targeted medications like sildenafil are co-administered with antihypertensive drugs to avoid excessive systemic hypotension, as recommended by the European Heart Journal 1
Sildenafil Interaction with Nitrates and Effects on Blood Pressure
Contraindications and Interactions
- The combination of sildenafil with organic nitrates is absolutely contraindicated due to synergistic and potentially life-threatening hypotension, as recommended by the American College of Cardiology 5, 6
- Nitrates are contraindicated within 24 hours after sildenafil use, and sildenafil is contraindicated within 24 hours after nitrate use, according to the American College of Cardiology guidelines 5, 6
- The American Heart Association suggests that tadalafil requires a 48-hour washout period before nitrate administration 5, 6
- The suitable delay for vardenafil has not been definitively determined, though blood pressure generally returns to baseline by 24 hours, as stated by the American College of Cardiology 5, 6
Effects on Pulmonary Arterial Hypertension
- Sildenafil reduces mean pulmonary artery pressure and pulmonary vascular resistance while increasing cardiac index in patients with pulmonary arterial hypertension, as recognized by the American College of Chest Physicians 7, 8
- The American College of Chest Physicians recommends sildenafil as effective for pulmonary arterial hypertension, improving exercise capacity, functional class, and hemodynamic parameters 7, 8